News

Published on 1 Dec 2021 on MSN News

BioCryst (BCRX) Begins Enrollment in PNH Study on BCX9930


Article preview image

BioCryst Pharmaceuticals, Inc. BCRX announced that it has enrolled the first patient in the pivotal...

NASDAQ.BCRX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q4 2023 Earnings Call Transcript

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q4 2023 Earnings Call Transcript February 26, 2024 B...

Insider Monkey via Yahoo Finance 28 Feb 2024

What's Going On With BioCryst Stock After Earnings? - BioCryst Pharma (NASDAQ:BCRX)

BioCryst Pharmaceuticals, Inc. BCRX shares are flat Monday after the company reported its fourth-...

Benzinga 26 Feb 2024

BioCryst Pharmaceuticals Inc (BCRX) Reports Growth in ORLADEYO Revenue and Projects ...

ORLADEYO Revenue: Q4 net revenue of $90.9 million, contributing to $326.0 million for FY 2023, ma...

GuruFocus.com via Yahoo Finance 26 Feb 2024

Fed's favorite inflation gauge looms next week — plus, what we want from 2 portfolio earnings...

Wall Street is paying closer attention the Fed's preferred inflation gauge than usual. TJX Cos. a...

CNBC 24 Feb 2024

BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) recent 18% pullback adds to one-year year losses,...

Key Insights Given the large stake in the stock by institutions, BioCryst Pharmaceuticals' stock ...

Simply Wall St. via Yahoo Finance 12 Nov 2023

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q3 2023 Earnings Call Transcript

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q3 2023 Earnings Call Transcript November 2, 2023 Bi...

Insider Monkey via Yahoo Finance 3 Nov 2023

BioCryst Pharmaceuticals Inc (BCRX) Reports Q3 2023 Earnings: ORLADEYO Revenue Up by 29.8% YoY

<img src=https://s.yimg.com/ny/api/res/1.2/dnHtfGdy.NsUznt3bthEqw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTM2M...

GuruFocus.com via Yahoo Finance 2 Nov 2023

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q2 2023 Earnings Call Transcript

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q2 2023 Earnings Call Transcript August 3, 2023 BioC...

Insider Monkey via Yahoo Finance 4 Aug 2023

BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) institutional shareholders had a great week as...

Key Insights Given the large stake in the stock by institutions, BioCryst Pharmaceuticals' stock ...

Simply Wall St. via Yahoo Finance 9 May 2023

Lacklustre Performance Is Driving BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) Low P/S

BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) price-to-sales (or "P/S") ratio of 5.6x might make...

Simply Wall St. via Yahoo Finance 17 Apr 2023